08/09/2021

Treatment Without Borders: The EU Case for Equitable Patient Access to Advanced Therapies

25/05/2021

Alliance for Regenerative Medicine, European Federation of Pharmaceutical Industries and Associations, and European Association for Bioindustries Call for Advanced Therapies to be Exempt from EU GMO Legislation

EuropaBio welcomes the in-depth opinion of the European Group on Ethics on the uses of genome editing and thanks the Group for raising the awareness of a technology which will enable the development of many solutions for healthy people and planet.
20/05/2021

EuropaBio Patient BioForum: Advancing Patient Access to Innovative Treatments

20/05/2021

Advanced Therapies bring tranformational value to European patients

11/05/2021

Taking health up a gear: value of advanced therapies

Advanced therapies have ground-breaking therapeutic potential, particularly in disease areas where there is an unmet medical need and available therapeutic options are absent or inadequate. These […]
29/04/2021

EuropaBio on NGT study: A positive step towards delivering innovation

EuropaBio welcomes the in-depth opinion of the European Group on Ethics on the uses of genome editing and thanks the Group for raising the awareness of a technology which will enable the development of many solutions for healthy people and planet.
31/03/2021

EuropaBio response to the EGE report ‘Ethics of Genome Editing’

EuropaBio welcomes the in-depth opinion of the European Group on Ethics on the uses of genome editing and thanks the Group for raising the awareness of a technology which will enable the development of many solutions for healthy people and planet.
30/11/2020

Call for more effective EU regulation of Clinical Trials with Advanced Therapy Medicinal Products consisting of or containing Genetically Modified Organisms

Call for more effective EU regulation of clinical trials with Advanced Therapy Medicinal Products consisting of or containing Genetically Modified Organisms
19/10/2020

Application of the ATMP Hospital Exemption in the EU

EuropaBio and its members would like to engage the European Commission and all relevant stakeholders in a discussion on the future use of the HE in the context of the new EU Pharmaceutical Strategy and its accompanying actions.
24/09/2020

Genome editing FAQ

Genome editing is an advance in biological tools with the potential for a wide range of applications.
24/08/2020

Genome-Edited Products and Projects: Resources and Examples

This is a non-exhaustive list of over 200 genome-editing or viral vector related products and research projects, drawn from various resources and covering healthcare, industrial and agricultural biotech
20/05/2020

EuropaBio position on Germline Genome Editing

EuropaBio and its members strongly believe that genome editing will enable the development of many solutions to the grand challenges facing both people and planet. In medicine, genome editing offers the prospect of saving lives and tackling some of the most devastating genetic diseases.
30/04/2020

World Haemophilia Day – Interview with Amanda Bok (EHC)

The 30th anniversary of World Haemophilia Day helps to illustrate the importance to support the bleeding disorders community. Read our interview with Amanda Bok, CEO of the European Haemophilia Consortium (EHC) & Co-Chair of EuropaBio's Patients BioForum.
28/04/2020

Primary Immunodeficiencies Week – Interview Johan Prevot (IPOPI)

On the occasion of World PI Week we interviewed Johan Prevot, Executive Director of the International Patient Organisation for Primary Immunodeficiencies (IPOPI).
17/04/2020

World Haemophilia Day – Interview with Dr. Ian Winburn (Pfizer)

On the occasion of World Haemophilia Day we had the pleasure to interview Dr. Ian Winburn, Global Medical Lead within Pfizer’s Rare Disease Business Unit.
17/04/2020

World Haemophilia Day – A Message from Paul Perrault (CSL Behring)

On the occassion of World Haemophilia Day, read a message from Paul Perreault, CEO of CSL Behring.
17/04/2020

World Haemophilia Week – Interview with Philip Wood (Sobi)

During World Haemophilia Week, we caught up with Sobi's Head of Haematology, Philip Wood.
09/03/2020

EuropaBio Position & Policy Recommendations to support EU ATMP Innovation

To ensure the EU remains a leader in ATMP innovation, this paper outlines and elaborates EuropaBio’s position and policy recommendations to the European Commission across three key focus areas.
26/01/2020

What if we could definitively cure AIDS

A combination of antiviral therapy and genome editing has succeeded in removing the HIV virus from infected mice.
25/01/2020

Create immunotherapy treatments for cancer

Immunotherapy has a long history of use against cancer: in the 1890’s bacteria was injected into a tumour in an attempt to encourage a response by the immune system against the cancer.
Become a member